3D Printing of Biomaterials
3D printing is the technique of developing three- dimensional shape of biomaterials by using potential of laptop control. With appreciate to the nano-scale dimensions the biomaterials are categorised into three sorts as- Nano-particle (3D), Nano-fiber(2D) and Nano-sheet (1D). 3D bioprinting is the formation of severa phone patterns with the aid of the usage of printing methods alongside with the layer-by-layer approach to produce tissue mimetic buildings barring any damage in cellphone feature that can be similarly used in tissue engineering. Electrospinning science skill deposition of polymer nanofibers on an object with the aid of the usage of excessive voltage to a liquid polymer solution. Bioprinting helps in the lookup of capsules and tablets by using printing tissues and organs. It is additionally used for micro gadgets and microarrays. The 3D printing substances market is anticipated to attain USD 1,409.5 Million via 2021 from USD 530.1 Million in 2016, at a CAGR of 21.60%.
Related Conference of 3D Printing of Biomaterials
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
3D Printing of Biomaterials Conference Speakers
Recommended Sessions
- 3D Printing of Biomaterials
- Advanced Biomaterials
- Bio-based Materials and Sustainability
- Bio-Nanomaterials
- Biodegradable Biomaterials
- Biofunctional Materials
- Bioinspired Materials
- Bioinspired Materials
- Biomaterials
- Biomaterials and Nanotechnology
- Biomaterials and Nanotechnology
- Biomaterials Applications
- Biomaterials Applications
- Biomaterials Companies and Market Analysis
- Biomaterials in Drug Delivery Systems
- Biophotonics and Biomedical Optics
- Dental Biomaterials
- Polymer Biomaterials
- Properties of Biomaterials
- Tissue Engineering and Regenerative Medicine
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)